Additionally, copeptin levels have been found to be positively associated with the myocardial infarct size and the process of adverse remodeling in patients with STEMI [81], as well as with the angiographic severity of coronary artery disease in patients with unstable angina [82]. This evidence concerns the gene AVP and coronary artery disorder.